Cargando…
Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644084/ https://www.ncbi.nlm.nih.gov/pubmed/29037246 http://dx.doi.org/10.1186/s12974-017-0978-3 |
_version_ | 1783271661255000064 |
---|---|
author | Prajeeth, Chittappen K. Kronisch, Julius Khorooshi, Reza Knier, Benjamin Toft-Hansen, Henrik Gudi, Viktoria Floess, Stefan Huehn, Jochen Owens, Trevor Korn, Thomas Stangel, Martin |
author_facet | Prajeeth, Chittappen K. Kronisch, Julius Khorooshi, Reza Knier, Benjamin Toft-Hansen, Henrik Gudi, Viktoria Floess, Stefan Huehn, Jochen Owens, Trevor Korn, Thomas Stangel, Martin |
author_sort | Prajeeth, Chittappen K. |
collection | PubMed |
description | BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but not Th17 effectors activate microglia. However, it is not clear which cells are targets of Th17 effectors in the CNS. METHODS: To understand the effects driven by Th17 cells in the CNS, we induced experimental autoimmune encephalomyelitis in wild-type mice and CD4(+) T cell-specific integrin α4-deficient mice where trafficking of Th1 cells into the CNS was affected. We compared microglial and astrocyte response in the brain and spinal cord of these mice. We further treated astrocytes with supernatants from highly pure Th1 and Th17 cultures and assessed the messenger RNA expression of neurotrophic factors, cytokines and chemokines, using real-time PCR. Data obtained was analyzed using the Kruskal-Wallis test. RESULTS: We observed in α4-deficient mice weak microglial activation but comparable astrogliosis to that of wild-type mice in the regions of the brain populated with Th17 infiltrates, suggesting that Th17 cells target astrocytes and not microglia. In vitro, in response to supernatants from Th1 and Th17 cultures, astrocytes showed altered expression of neurotrophic factors, pro-inflammatory cytokines and chemokines. Furthermore, increased expression of chemokines in Th1- and Th17-treated astrocytes enhanced recruitment of microglia and transendothelial migration of Th17 cells in vitro. CONCLUSION: Our results demonstrate the delicate interaction between T cell subsets and glial cells and how they communicate to mediate their effects. Effectors of Th1 act on both microglia and astrocytes whereas Th17 effectors preferentially target astrocytes to promote neuroinflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-017-0978-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5644084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56440842017-10-18 Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties Prajeeth, Chittappen K. Kronisch, Julius Khorooshi, Reza Knier, Benjamin Toft-Hansen, Henrik Gudi, Viktoria Floess, Stefan Huehn, Jochen Owens, Trevor Korn, Thomas Stangel, Martin J Neuroinflammation Research BACKGROUND: Autoreactive Th1 and Th17 cells are believed to mediate the pathology of multiple sclerosis in the central nervous system (CNS). Their interaction with microglia and astrocytes in the CNS is crucial for the regulation of the neuroinflammation. Previously, we have shown that only Th1 but not Th17 effectors activate microglia. However, it is not clear which cells are targets of Th17 effectors in the CNS. METHODS: To understand the effects driven by Th17 cells in the CNS, we induced experimental autoimmune encephalomyelitis in wild-type mice and CD4(+) T cell-specific integrin α4-deficient mice where trafficking of Th1 cells into the CNS was affected. We compared microglial and astrocyte response in the brain and spinal cord of these mice. We further treated astrocytes with supernatants from highly pure Th1 and Th17 cultures and assessed the messenger RNA expression of neurotrophic factors, cytokines and chemokines, using real-time PCR. Data obtained was analyzed using the Kruskal-Wallis test. RESULTS: We observed in α4-deficient mice weak microglial activation but comparable astrogliosis to that of wild-type mice in the regions of the brain populated with Th17 infiltrates, suggesting that Th17 cells target astrocytes and not microglia. In vitro, in response to supernatants from Th1 and Th17 cultures, astrocytes showed altered expression of neurotrophic factors, pro-inflammatory cytokines and chemokines. Furthermore, increased expression of chemokines in Th1- and Th17-treated astrocytes enhanced recruitment of microglia and transendothelial migration of Th17 cells in vitro. CONCLUSION: Our results demonstrate the delicate interaction between T cell subsets and glial cells and how they communicate to mediate their effects. Effectors of Th1 act on both microglia and astrocytes whereas Th17 effectors preferentially target astrocytes to promote neuroinflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-017-0978-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-16 /pmc/articles/PMC5644084/ /pubmed/29037246 http://dx.doi.org/10.1186/s12974-017-0978-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Prajeeth, Chittappen K. Kronisch, Julius Khorooshi, Reza Knier, Benjamin Toft-Hansen, Henrik Gudi, Viktoria Floess, Stefan Huehn, Jochen Owens, Trevor Korn, Thomas Stangel, Martin Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title_full | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title_fullStr | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title_full_unstemmed | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title_short | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
title_sort | effectors of th1 and th17 cells act on astrocytes and augment their neuroinflammatory properties |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644084/ https://www.ncbi.nlm.nih.gov/pubmed/29037246 http://dx.doi.org/10.1186/s12974-017-0978-3 |
work_keys_str_mv | AT prajeethchittappenk effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT kronischjulius effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT khorooshireza effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT knierbenjamin effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT tofthansenhenrik effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT gudiviktoria effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT floessstefan effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT huehnjochen effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT owenstrevor effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT kornthomas effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties AT stangelmartin effectorsofth1andth17cellsactonastrocytesandaugmenttheirneuroinflammatoryproperties |